NDC 80425-0283-01 - Methocarbamol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0283
- Requested NDC
- 80425-0283-01
- Package NDCs from labels
- 80425-0283-1, 80425-0283-2, 80425-0283-3, 80425-0283-4, 80425-0283-5, 80425-0283-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methocarbamol - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0283-1 | Methocarbamol | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 80425-0283-2 | Methocarbamol | 60 in 1 BOTTLE | TABLET | 60 | 3 | |
| 80425-0283-3 | Methocarbamol | 90 in 1 BOTTLE | TABLET | 90 | 3 | |
| 80425-0283-4 | Methocarbamol | 120 in 1 BOTTLE | TABLET | 120 | 3 | |
| 80425-0283-5 | Methocarbamol | 180 in 1 BOTTLE | TABLET | 180 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0283 | METHOCARBAMOL TABLET [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 3 | Current NDC, 5 package rows | 20250102_f6567e04-12f0-fa79-e053-2995a90a9a0e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0283-1 | EA - Each | 80425-0283 | 21ad4035-e96c-4ea2-a554-99e52baa97dd | 1 | 2023-06-06 |
| 80425-0283-2 | EA - Each | 80425-0283 | da3849c3-560f-4914-82be-2a14544bd652 | 1 | 2023-06-06 |
| 80425-0283-3 | EA - Each | 80425-0283 | 60d3fd48-4241-4935-8761-e177eff960f4 | 1 | 2023-06-06 |
| 80425-0283-4 | EA - Each | 80425-0283 | 28f053be-6da2-4ae5-967e-cbb4ac58f891 | 1 | 2023-06-06 |
| 80425-0283-5 | EA - Each | 80425-0283 | 16bef713-1136-4b15-bf56-71d8bab14efe | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | cfdc0d68-00ad-44d6-b932-819cc3d5d60e | 2026-06-26 | Warnings, Adverse reactions | ANDA040489 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | b81a8e64-ae41-409b-94a6-b36cb50bc25d | 2026-06-26 | Warnings, Adverse reactions | ANDA040489 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | HAWAII REPACK, INC. | c4744824-4c74-411d-aa8e-c63ee9d89913 | 2026-06-25 | Warnings, Adverse reactions | ANDA040489 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Preferred Pharmaceuticals Inc. | 43f83b87-e169-46fe-98bd-6af373595bd3 | 2026-06-23 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Preferred Pharmaceuticals Inc. | 4ef1c2c0-31e1-4f85-b645-ff47a057a994 | 2026-06-23 | Warnings, Adverse reactions | ANDA040489 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Preferred Pharmaceuticals, Inc | 425abc3b-2111-4fac-bf27-b685d1e657af | 2026-06-23 | Warnings, Adverse reactions | ANDA040489 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Preferred Pharmaceuticals Inc. | e03878d3-d780-4e7f-b828-20ac2a109933 | 2026-06-23 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Direct_rx | 4c5c8933-a4b5-f9c2-e063-6294a90a6f00 | 2026-06-16 | Warnings, Adverse reactions | ANDA040489 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | 5af36a83-2b36-4fe2-8c6a-61b551621421 | 2026-06-16 | Warnings, Adverse reactions | ANDA040489 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | cc004f5c-d5fc-48c5-9f37-c59b9c37e113 | 2026-06-16 | Warnings, Adverse reactions | ANDA040489 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | 9076b4ad-17be-4933-a975-7bf80cc92b49 | 2026-06-10 | Warnings, Adverse reactions | ANDA040489 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | 3f8aed5d-ba8d-4c32-872b-08ab15240cc1 | 2026-06-10 | Warnings, Adverse reactions | ANDA040489 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Cardinal Health 107, LLC | 50603730-9f69-4ed7-bccf-31c474f83e14 | 2026-06-05 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | St. Mary's Medical Park Pharmacy | fd8cac57-9664-1fa0-e053-6294a90af872 | 2026-06-02 | Warnings, Adverse reactions | ANDA040489 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | 6466438c-4609-4554-8919-35710a1b556d | 2026-06-01 | Warnings, Adverse reactions | ANDA040489 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | 3212f121-9428-4186-8f00-accf08bca473 | 2026-05-29 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | 33f89a57-f65d-4e99-a3a3-690ef805d869 | 2026-05-27 | Warnings, Adverse reactions | ANDA040489 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | 6af87b4e-6507-4190-b043-a6d3b440314a | 2026-05-27 | Warnings, Adverse reactions | ANDA040489 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Coupler LLC | 52b87514-e6e0-ab57-e063-6394a90a6b23 | 2026-05-26 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | NuCare Pharmaceuticals,Inc. | 71c21226-cd96-33ed-e053-2995a90a5269 | 2026-05-22 | Warnings, Adverse reactions | 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.